Inflammatory response in preeclampsia

Molecular Aspects of Medicine

Volumn 28, Issue 2, 2007, Pages 210-219

  Schiessl, Barbara ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

AT 1; Cytokines; HIF; Inflammation; Paternity; Preeclampsia

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; AUTOANTIBODY; CYTOKINE; HLA ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1;

HUMAN; HYPOXIA; IMMUNE SYSTEM; IMMUNOGENICITY; INFLAMMATION; MONOCYTE; NATURAL KILLER CELL; PATERNITY; PREECLAMPSIA; REVIEW;

CYTOKINES; FEMALE; HLA ANTIGENS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; PRE-ECLAMPSIA; PREGNANCY;

EID: 34249716332     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.04.004     Document Type: Review

References (50)

1. Al Othman S., Omu A.E., Diejomaoh F.M., Al Yatama M., and Al Qattan F. Differential levels of interleukin 6 in maternal and cord sera and placenta in women with pre-eclampsia. Gynecol. Obstet. Invest. 52 1 (2001) 60-65
2. Benetos A., Topouchian J., Ricard S., Gautier S., Bonnardeaux A., Asmar R., et al. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 26 1 (1995) 44-47
3. Benyo D.F., Miles T.M., and Conrad K.P. Hypoxia stimulates cytokine production by villous explants from the human placenta. J. Clin. Endocrinol. Metab. 82 5 (1997) 1582-1588
4. Benyo D.F., Smarason A., Redman C.W., Sims C., and Conrad K.P. Expression of inflammatory cytokines in placentas from women with preeclampsia. J. Clin. Endocrinol. Metab. 86 6 (2001) 2505-2512
5. Caniggia I., and Winter J.L. Adriana and Luisa Castellucci Award Lecture 2001 hypoxia inducible factor-1: Oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies - A review. Placenta 23 (2002) S47-S57
6. Caniggia I., Mostachfi H., Winter J., Gassmann M., Lye S.J., Kuliszewski M., et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGF beta(3). J. Clin. Invest. 105 5 (2000) 577-587
7. Chaouat G., Tranchot D.J., Volumenie J.L., Menu E., Gras G., Delage G., et al. Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann. Am. J. Reprod. Immunol. 37 6 (1997) 427-434
8. Conrad K.P., Miles T.M., and Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am. J. Reprod. Immunol. 40 2 (1998) 102-111
9. Dechend R., Homuth V., Wallukat G., Kreuzer J., Park J.K., Theuer J., et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101 20 (2000) 2382-2387
10. Dechend R., Homuth V., Wallukat G., Muller D.N., Krause M., Dudenhausen J., et al. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J. Soc. Gynecol. Investig. 13 2 (2006) 79-86
11. Dempsey J.C., Sorensen T.K., Qiu C.F., Luthy D.A., and Williams M.A. History of abortion and subsequent risk of preeclampsia. J. Reprod. Med. 48 7 (2003) 509-514
12. Greer I.A., Lyall F., Perera T., Boswell F., and Macara L.M. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?. Obstet. Gynecol. 84 6 (1994) 937-940
13. Hahn S., Huppertz B., and Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation?. Placenta 26 7 (2005) 515-526
14. Haller H., Ziegler E.M., Homuth V., Drab M., Eichhorn J., Nagy Z., et al. Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients. Hypertension 29 1 Pt 2 (1997) 291-296
15. Haller H., Hempel A., Homuth V., Mandelkow A., Busjahn A., Maasch C., et al. Endothelial-cell permeability and protein kinase C in pre-eclampsia. Lancet 351 9107 (1998) 945-949
16. Hanssens M., Keirse M.J., Spitz B., and van Assche F.A. Angiotensin II levels in hypertensive and normotensive pregnancies. Br. J. Obstet. Gynaecol. 98 2 (1991) 155-161
17. Hara N., Fujii T., Yamashita T., Kozuma S., Okai T., and Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody "87G" and anti-cytokeratin antibody CAM5.2. Am. J. Reprod. Immunol. 36 6 (1996) 349-358
18. Herse F., Dechend R., Harsem N.K., Wallukat G., Janke J., Qadri F., Hering L., Muller D.N., Luft F.C., and Staff A.C. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 49 (2007) 604-611
19. Knight M., Redman C.W., Linton E.A., and Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol. 105 6 (1998) 632-640
20. Koch C.A., and Platt J.L. Natural mechanisms for evading graft rejection: the fetus as an allograft. Springer Semin. Immunopathol. 25 2 (2003) 95-117
21. Kupferminc M.J., Peaceman A.M., Wigton T.R., Tamura R.K., Rehnberg K.A., and Socol M.L. Immunoreactive tumor necrosis factor-alpha is elevated in maternal plasma but undetected in amniotic fluid in the second trimester. Am. J. Obstet. Gynecol. 171 4 (1994) 976-979
22. Le Bouteiller P. HLA-G in the human placenta: expression and potential functions. Biochem. Soc. Trans. 28 2 (2000) 208-212
23. Loke Y.W., Hiby S., and King A. Human leucocyte antigen-G and reproduction. J. Reprod. Immunol. 43 2 (1999) 235-242
24. Luppi P., and Deloia J.A. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin. Immunol. 118 2-3 (2006) 268-275
25. Mahomed N., and Moodley J. Pre-eclampsia - a problem of primipaternity not primigravidity?. J. Obstet. Gynaecol. 20 5 (2000) 472-474
26. Mor G., Gutierrez L.S., Eliza M., Kahyaoglu F., and Arici A. Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am. J. Reprod. Immunol. 40 2 (1998) 89-94
27. Munno I., Chiechi L.M., Lacedra G., Putignano G., Patimo C., Lobascio A., et al. Spontaneous and induced release of prostaglandins, interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha by placental tissue from normal and preeclamptic pregnancies. Am. J. Reprod. Immunol. 42 6 (1999) 369-374
28. Rajakumar A., and Conrad K.P. Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol. Reprod. 63 2 (2000) 559-569
29. Rajakumar A., Whitelock K.A., Weissfeld L.A., Daftary A.R., Markovic N., and Conrad K.P. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2 alpha, in placentas from women with preeclampsia. Biol. Reprod. 64 2 (2001) 499-506
30. Rein D.T., Breidenbach M., Honscheid B., Friebe-Hoffmann U., Engel H., Gohring U.J., et al. Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 23 4-5 (2003) 119-125
31. Rinehart B.K., Terrone D.A., Lagoo-Deenadayalan S., Barber W.H., Hale E.A., Martin Jr. J.N., et al. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am. J. Obstet. Gynecol. 181 4 (1999) 915-920
32. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161 5 (1989) 1200-1204
33. Sacks G.P., Studena K., Sargent K., and Redman C.W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol. 179 1 (1998) 80-86
34. Sacks G.P., Redman C.W., and Sargent I.L. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin. Exp. Immunol. 131 3 (2003) 490-497
35. Sacks G.P., Seyani L., Lavery S., and Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum. Reprod. 19 4 (2004) 1025-1030
36. Saftlas A.F., Levine R.J., Klebanoff M.A., Martz K.L., Ewell M.G., Morris C.D., et al. Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am. J. Epidemiol. 157 12 (2003) 1108-1114
37. Saftlas A.F., Beydoun H., and Triche E. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet. Gynecol. 106 1 (2005) 162-172
38. Saito S., and Sakai M. Th1/Th2 balance in preeclampsia. J. Reprod. Immunol. 59 2 (2003) 161-173
39. Saito S., Sakai M., Sasaki Y., Tanebe K., Tsuda H., and Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin. Exp. Immunol. 117 3 (1999) 550-555
40. Sargent I.L., Borzychowski A.M., and Redman C.W. NK cells and human pregnancy-an inflammatory view. Trends Immunol. 27 9 (2006) 399-404
41. Schneider K., Knutson F., Tamsen L., and Sjoberg O. HLA antigen sharing in preeclampsia. Gynecol. Obstet. Invest. 37 2 (1994) 87-90
42. Sibai B.M. Immunologic aspects of preeclampsia. Clin. Obstet. Gynecol. 34 1 (1991) 27-34
43. Sibai B.M. Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin. Perinatol. 30 1 (2006) 16-19
44. Stallmach T., Hebisch G., Joller H., Kolditz P., and Engelmann M. Expression pattern of cytokines in the different compartments of the feto-maternal unit under various conditions. Reprod. Fertil. Dev. 7 6 (1995) 1573-1580
45. Steinborn A., Sohn C., Sayehli C., Niederhut A., Schmitt E., and Kaufmann M. Preeclampsia, a pregnancy-specific disease, is associated with fetal monocyte activation. Clin. Immunol. 100 3 (2001) 305-313
46. Sun S.G., Shen N., Zheng Y.H., and Shang T. Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta. Zhonghua Fu Chan Ke Za Zhi 41 7 (2006) 440-444
47. Trupin L.S., Simon L.P., and Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology 7 3 (1996) 240-244
48. Wang Y., and Walsh S.W. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J. Reprod. Immunol. 32 2 (1996) 157-169
49. Wegmann T.G., Lin H., Guilbert L., and Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol. Today 14 7 (1993) 353-356
50. Williams M.A., Farrand A., Mittendorf R., Sorensen T.K., Zingheim R.W., O'Reilly G.C., et al. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am. J. Epidemiol. 149 4 (1999) 323-329